Enjoy complimentary customisation on priority with our Enterprise License!
The hemodialysis and peritoneal dialysis market size is forecast to increase by USD 6.61 billion at a CAGR of 5.97% between 2023 and 2028. The global market is experiencing significant growth due to the rising prevalence of chronic kidney disease (CKD) worldwide. An estimated 15% of the global population suffers from CKD, leading to a swell in demand for dialysis treatments. Technological advancements in dialysis equipment and renal dialysis are also driving market growth, offering improved patient outcomes and enhanced convenience. However, the high cost associated with dialysis treatment and dialysis disposable devices remains a major challenge, with healthcare expenditure on dialysis accounting for a substantial portion of overall healthcare spending. Furthermore, vascular access problems and heart illnesses are common complications among dialysis patients, necessitating ongoing research and development of more effective and less invasive treatment options.
To learn more about the hemodialysis and peritoneal dialysis market report, Request Free Sample
The global market for hemodialysis and peritoneal dialysis is driven by the prevalence of chronic kidney disease (CKD) and the growing number of dialysis patients. According to the National Kidney Foundation, over 37 million adults in the US alone have CKD, and approximately 700,000 are undergoing dialysis treatment. The shortage of organ donors for kidney transplants and the advancements in technology, such as wearable hemodialyzers and home-based peritoneal dialysis, are expected to boost market growth. However, vascular access problems, risks and complications, including cardiac diseases and vascular access-related complications, such as peritonitis and mortality, remain significant challenges for dialysis services providers. Technology advancements in healthcare services, such as the development of more efficient hemodialyzers and minimally invasive vascular access methods, are being explored to address these challenges. The rising healthcare expenditure on dialysis treatment and the increasing incidence of acute kidney disease are also contributing to market growth.
The hemodialysis and peritoneal dialysis market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The devices segment is estimated to witness significant growth during the forecast period. The global market for hemodialysis and peritoneal dialysis caters to the growing need for renal replacement therapy among patients suffering from renal disease or renal failure. Two primary types of dialysis treatments are available: hemodialysis and peritoneal dialysis. The devices segment in this market comprises a range of medical devices and technology necessary for the delivery of these therapies. This segment plays a crucial role in facilitating hemodialysis and peritoneal dialysis procedures through dialysis machines, catheters, tubing sets, and associated accessories.
Further, in the hemodialysis devices sub-segment, essential components include hemodialysis machines, hemodialyzers, bloodline tubing sets, and water treatment systems. These devices are integral to the extracorporeal blood purification process, enabling the removal of waste products, excess fluid, and toxins from the bloodstream of patients with renal insufficiency disorders. The hemodialysis devices market caters to various patient populations, including those with diabetes, hypertension, and geriatric patients. The continuous innovation in this segment aims to enhance treatment efficacy, patient safety, and overall dialysis experience.
Get a glance at the market share of various segments. Request Free Sample
The devices segment accounted for USD 10.39 billion in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 37% to the growth of the global hemodialysis and peritoneal dialysis market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions, Request Free Sample
The global market for hemodialysis and peritoneal dialysis is experiencing significant growth due to the increasing prevalence of renal diseases such as chronic kidney disease (CKD), renal failure, and associated conditions like diabetes and hypertension, particularly in the geriatric population. In 2023, North America is expected to dominate the market, with the US and Canada holding the largest shares. This growth can be attributed to the high prevalence of CKD in the region, advanced healthcare infrastructure, and the presence of major market players. According to the Centers for Disease Control and Prevention (CDC), approximately 130,522 people initiated treatment for end-stage kidney disease (ESKD) in the US in 2020. The North American market's expansion is driven by the increasing number of patients requiring renal replacement therapy and the availability of reimbursement policies for dialysis treatments.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rising prevalence of CKD globally is the key driver of hemodialysis and peritoneal dialysis market growth. Chronic Kidney Disease (CKD) is a prevalent non-communicable condition affecting approximately 8.5%-9.5% of the global adult population. Diabetes and hypertension are significant contributors to the rising incidence of CKD, which is driving the need for CKD drugs. According to the World Health Organization (WHO), CKD is projected to rank as the fifth most common chronic illness by 2040. Major causes of CKD include diabetes, hypertension, vascular disease, and glomerulonephritis. In underdeveloped and developing countries, glomerulonephritis and interstitial nephritis are the leading causes due to high infection rates.
Further, organ donors remain crucial for kidney transplants, which are the preferred treatment for advanced stages of CKD. Technology advancements in dialysis therapies, including hemodialysis and peritoneal dialysis, have significantly improved patient outcomes and quality of life. Hemodialysis involves filtering blood outside the body, while peritoneal dialysis uses the peritoneal membrane as a natural filter. Both methods are essential for managing CKD and maintaining patient health until a suitable organ donor becomes available.
Technological advancements in dialysis equipment is the upcoming trend in the hemodialysis and peritoneal dialysis market. The global market for hemodialysis and peritoneal dialysis has experienced significant growth due to the increasing prevalence of chronic kidney disease (CKD) and the subsequent need for dialysis treatment. Organ donors and kidney transplants remain the ideal solution for end-stage renal disease patients, but technological advancements have expanded dialysis options for those who do not qualify for or cannot access transplants. Innovations such as wearable and portable dialysis devices have revolutionized the industry, offering enhanced mobility and convenience for patients.
For instance, wearable artificial kidney devices function like a natural kidney, continuously performing hemodialysis. These lightweight and compact devices enable patients to engage in daily activities while receiving treatment, providing greater independence and improved quality of life compared to traditional dialysis machines. The market is expected to continue growing as technology advances and meets the evolving needs of the dialysis patient population.
The high cost associated with dialysis treatment is a key challenge affecting hemodialysis and peritoneal dialysis market growth. The market face significant challenges due to the high cost of treatment, which poses financial burdens for patients, healthcare systems, and economies. The expenses related to dialysis encompass not only direct medical costs but also non-medical expenses and socioeconomic implications. For instance, in the US, the cost of hemodialysis varies significantly based on factors like insurance coverage, location, and treatment frequency.
Further, according to the Centers for Medicare and Medicaid Services, the monthly cost for an uninsured individual can range from USD 6,000 to USD 12,000. The prevalence of chronic kidney disease (CKD) is a major driver for the growth of this market, with an increasing number of organ donors and kidney transplants providing alternative solutions. Technology advancements continue to shape the market, offering more efficient and cost-effective dialysis options. However, the high cost remains a significant barrier to access for many patients.
The hemodialysis and peritoneal dialysis market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the hemodialysis and peritoneal dialysis market growth analysis report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
3M Co. - The company offers hemodialysis and peritoneal dialysis products such as 3M MEMBRANA PUREMA, 3M MEMBRANA DIAPES and 3M MEMBRANA SYNPHAN.
The hemodialysis and peritoneal dialysis market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The global hemodialysis and peritoneal dialysis market is experiencing significant growth due to the increasing prevalence of chronic kidney disease (CKD) and the growing geriatric population. According to the World Health Organization, over 14 million people worldwide require renal replacement therapy, with dialysis being the most common treatment modality for end-stage renal disease. Hemodialysis and peritoneal dialysis are two primary forms of renal replacement therapies. Conventional hemodialysis involves the use of a hemodialyzer and catheters for blood filtration, while home-based and hospital-based options are available. Technology advancements, such as short daily hemodialysis, nocturnal hemodialysis, and wearable devices, are improving patient outcomes and convenience.
Additionally, peritoneal dialysis involves the use of dialysis concentrates and a catheter to clean the blood through the lining of the abdominal cavity. This modality is gaining popularity due to its convenience and lower cost compared to hemodialysis. However, risks and complications, such as vascular access-related complications, cardiac diseases, peritonitis, and mortality, remain concerns. The healthcare expenditure for dialysis patients is high, with dialysis treatment costing up to USD 80,000 per year. Telemedicine and phozevel tablets are emerging technologies aimed at reducing costs and improving access to care. Despite these advancements, challenges such as heart illnesses, pneumonia, and diabetes continue to impact the market.
Market Scope |
|
Report Coverage |
Details |
Page number |
173 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.97% |
Market growth 2024-2028 |
USD 6.61 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.53 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, Canada, Denmark, China, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
3M Co., Allmed Medical Care Holdings Ltd., AngioDynamics Inc., ANGIPLAST Pvt. Ltd., Asahi Kasei Corp., Atlantic Biomedical Pvt. Ltd., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Boston Scientific Corp., Dialife SA, Fresenius SE and Co. KGaA, JMS Co. Ltd., Medical Components Inc., Medtronic Plc, Mitra Industries Pvt. Ltd., Nikkiso Co. Ltd., Nipro Medical Corp., Outset Medical Inc., Rockwell Medical Inc., Toray Industries Inc., V J Industries, and AWAK Technologies |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our hemodialysis and peritoneal dialysis market forecast report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this hemodialysis and peritoneal dialysis market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.